These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 24668891

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Multifunctional nanocarrier mediated co-delivery of doxorubicin and siRNA for synergistic enhancement of glioma apoptosis in rat.
    Cheng D, Cao N, Chen J, Yu X, Shuai X.
    Biomaterials; 2012 Feb; 33(4):1170-9. PubMed ID: 22061491
    [Abstract] [Full Text] [Related]

  • 4. A self-assembled polyjuglanin nanoparticle loaded with doxorubicin and anti-Kras siRNA for attenuating multidrug resistance in human lung cancer.
    Wen ZM, Jie J, Zhang Y, Liu H, Peng LP.
    Biochem Biophys Res Commun; 2017 Dec 02; 493(4):1430-1437. PubMed ID: 28958938
    [Abstract] [Full Text] [Related]

  • 5. Dual-targeting and pH/redox-responsive multi-layered nanocomplexes for smart co-delivery of doxorubicin and siRNA.
    Han L, Tang C, Yin C.
    Biomaterials; 2015 Aug 02; 60():42-52. PubMed ID: 25982552
    [Abstract] [Full Text] [Related]

  • 6. Hyperbranched-hyperbranched polymeric nanoassembly to mediate controllable co-delivery of siRNA and drug for synergistic tumor therapy.
    Jia HZ, Zhang W, Zhu JY, Yang B, Chen S, Chen G, Zhao YF, Feng J, Zhang XZ.
    J Control Release; 2015 Oct 28; 216():9-17. PubMed ID: 26272764
    [Abstract] [Full Text] [Related]

  • 7. Reversal of doxorubicin resistance in breast cancer by mitochondria-targeted pH-responsive micelles.
    Yu P, Yu H, Guo C, Cui Z, Chen X, Yin Q, Zhang P, Yang X, Cui H, Li Y.
    Acta Biomater; 2015 Mar 28; 14():115-24. PubMed ID: 25498306
    [Abstract] [Full Text] [Related]

  • 8. The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells.
    Cao N, Cheng D, Zou S, Ai H, Gao J, Shuai X.
    Biomaterials; 2011 Mar 28; 32(8):2222-32. PubMed ID: 21186059
    [Abstract] [Full Text] [Related]

  • 9. Gold nanocage decorated pH-sensitive micelle for highly effective photothermo-chemotherapy and photoacoustic imaging.
    Zhou G, Xiao H, Li X, Huang Y, Song W, Song L, Chen M, Cheng D, Shuai X.
    Acta Biomater; 2017 Dec 28; 64():223-236. PubMed ID: 29030300
    [Abstract] [Full Text] [Related]

  • 10. A biodegradable polymersome containing Bcl-xL siRNA and doxorubicin as a dual delivery vehicle for a synergistic anticancer effect.
    Kim HO, Kim E, An Y, Choi J, Jang E, Choi EB, Kukreja A, Kim MH, Kang B, Kim DJ, Suh JS, Huh YM, Haam S.
    Macromol Biosci; 2013 Jun 28; 13(6):745-54. PubMed ID: 23613425
    [Abstract] [Full Text] [Related]

  • 11. Redox-responsive mesoporous silica nanoparticles: a physiologically sensitive codelivery vehicle for siRNA and doxorubicin.
    Ma X, Teh C, Zhang Q, Borah P, Choong C, Korzh V, Zhao Y.
    Antioxid Redox Signal; 2014 Aug 10; 21(5):707-22. PubMed ID: 23931896
    [Abstract] [Full Text] [Related]

  • 12. Redox and pH-responsive degradable micelles for dually activated intracellular anticancer drug release.
    Chen W, Zhong P, Meng F, Cheng R, Deng C, Feijen J, Zhong Z.
    J Control Release; 2013 Aug 10; 169(3):171-9. PubMed ID: 23306022
    [Abstract] [Full Text] [Related]

  • 13. Co-Delivery of Doxorubicin and Survivin shRNA-Expressing Plasmid Via Microenvironment-Responsive Dendritic Mesoporous Silica Nanoparticles for Synergistic Cancer Therapy.
    Li Z, Zhang L, Tang C, Yin C.
    Pharm Res; 2017 Dec 10; 34(12):2829-2841. PubMed ID: 28948461
    [Abstract] [Full Text] [Related]

  • 14. Reduction/photo dual-responsive polymeric prodrug nanoparticles for programmed siRNA and doxorubicin delivery.
    Wu M, Li J, Lin X, Wei Z, Zhang D, Zhao B, Liu X, Liu J.
    Biomater Sci; 2018 May 29; 6(6):1457-1468. PubMed ID: 29770812
    [Abstract] [Full Text] [Related]

  • 15. Co-delivery of doxorubicin and siRNA by a simplified platform with oligodeoxynucleotides as a drug carrier.
    Liu T, Wang M, Wang T, Yao Y, Zhang N.
    Colloids Surf B Biointerfaces; 2015 Feb 01; 126():531-40. PubMed ID: 25618822
    [Abstract] [Full Text] [Related]

  • 16. Triple-Layered pH-Responsive Micelleplexes Loaded with siRNA and Cisplatin Prodrug for NF-Kappa B Targeted Treatment of Metastatic Breast Cancer.
    Yu H, Guo C, Feng B, Liu J, Chen X, Wang D, Teng L, Li Y, Yin Q, Zhang Z, Li Y.
    Theranostics; 2016 Feb 01; 6(1):14-27. PubMed ID: 26722370
    [Abstract] [Full Text] [Related]

  • 17. Near Infrared-Guided Smart Nanocarriers for MicroRNA-Controlled Release of Doxorubicin/siRNA with Intracellular ATP as Fuel.
    Zhang P, Wang C, Zhao J, Xiao A, Shen Q, Li L, Li J, Zhang J, Min Q, Chen J, Chen HY, Zhu JJ.
    ACS Nano; 2016 Mar 22; 10(3):3637-47. PubMed ID: 26905935
    [Abstract] [Full Text] [Related]

  • 18. Self assembled dual responsive micelles stabilized with protein for co-delivery of drug and siRNA in cancer therapy.
    Aji Alex MR, Nehate C, Veeranarayanan S, Kumar DS, Kulshreshtha R, Koul V.
    Biomaterials; 2017 Jul 22; 133():94-106. PubMed ID: 28433941
    [Abstract] [Full Text] [Related]

  • 19. pH-responsive DNA nanomicelles for chemo-gene synergetic therapy of anaplastic large cell lymphoma.
    Li Y, Yue S, Cao J, Zhu C, Wang Y, Hai X, Song W, Bi S.
    Theranostics; 2020 Jul 22; 10(18):8250-8263. PubMed ID: 32724469
    [Abstract] [Full Text] [Related]

  • 20. Co-delivery of doxorubicin and arsenite with reduction and pH dual-sensitive vesicle for synergistic cancer therapy.
    Zhang L, Xiao H, Li J, Cheng D, Shuai X.
    Nanoscale; 2016 Jul 07; 8(25):12608-17. PubMed ID: 26731009
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.